Assess whether related-party sales should be backed out of valuation (b6033e)

SITUATION Environmental known-condition schedule arrived with a CIM that omitted a material litigation for environmental diligence manager. That is a M&A Due Diligence Earnings and Revenue Quality decision on related-party sales should be in a health-system acquiring a specialty practice.

DECISION Environmental diligence manager in a health-system acquiring a specialty practice must choose Proceed / Reprice / Walk / Hold using environmental known-condition schedule after a CIM that omitted a material litigation.

HYPOTHESES TO TEST 1. The population in environmental known-condition schedule is the one a CIM that omitted a material litigation named, so Proceed follows for this Earnings and Revenue Quality file. 2. The population in environmental known-condition schedule is adjacent only to a CIM that omitted a material litigation; Reprice is the honest M&A Due Diligence call. 3. A health-system acquiring a specialty practice already contained a CIM that omitted a material litigation before environmental known-condition schedule arrived; no new Earnings and Revenue Quality path. 4. Provenance on environmental known-condition schedule after a CIM that omitted a material litigation is broken; do not pick Proceed or Reprice yet.

ANALYSIS REQUIRED 1. Test whether a CIM that omitted a material litigation is a diligence gap, a price chip, or a walk-away. 2. Separate a one-off add-back from a recurring earnings issue in environmental known-condition schedule. 3. Map reps, earnout mechanics, and integration risk a health-system acquiring a specialty practice would inherit. 4. For this M&A Due Diligence Earnings and Revenue Quality file, read environmental known-condition schedule against a CIM that omitted a material litigation and write the one fact that would move related-party sales should be for environmental diligence manager.

RECOMMENDATION Choose Proceed / Reprice / Walk / Hold on this M&A Due Diligence / Earnings and Revenue Quality packet (environmental known-condition schedule after a CIM that omitted a material litigation). If environmental known-condition schedule cannot force a M&A Due Diligence label under Earnings and Revenue Quality, stop. Do not invent missing evidence a health-system acquiring a specialty practice does not have.

COMMAND RETURNS - Bottom-line M&A Due Diligence option on related-party sales should be, then the evidence in environmental known-condition schedule, then the action for environmental diligence manager - Hypothesis scorecard against environmental known-condition schedule: supported / rejected / untestable - Named option among Proceed, Reprice, Walk and the fact that kills the others - Owner and next date for environmental diligence manager in a health-system acquiring a specialty practice